Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b9be04077b77627eecf59b258f69df6 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 |
filingDate |
2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_937ee2b7b236c704defe11e0ad0b6547 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d404907d8343403f99168355fb46cffe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89109d278b57a322eb9244c4f5991287 |
publicationDate |
2012-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2012158532-A |
titleOfInvention |
Anti-p75 human monoclonal antibody |
abstract |
An object of the present invention is to provide a human heavy chain variable region antibody that binds to the neurotrophic factor receptor p75, a measurement method using the antibody, and a pharmaceutical composition or reagent containing the antibody. [Solution] Human heavy chain variable region having binding activity to neurotrophic factor receptor p75 by repeating the step of selecting phage for expressing human heavy chain variable region antibody that binds to neurotrophic factor receptor p75 expressing human cultured cells multiple times. Succeeded in obtaining antibodies. Thus, a human cell, a human heavy chain variable region antibody that binds to neurotrophic factor receptor p75 in human tissue, and a composition for detecting neurotrophic factor receptor p75 using the antibody, neurotrophic factor receptor A p75 binding pharmaceutical composition was provided. [Selection] Figure 3 |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022166806-A1 |
priorityDate |
2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |